Devon J. Shedlock, Ph.D.

Chief Scientific Officer, Cell Therapy

Dr. Shedlock is our Chief Scientific Officer, Cell Therapy, after joining Poseida as our first employee in 2015 and most recently serving as Senior Vice President of Research & Development. He is a key scientific contributor in the application of the Company’s proprietary gene engineering platform technologies to develop novel cell therapy programs. Before joining Poseida, he held positions as an adjunct assistant professor of pathology and laboratory medicine at the Perelman School of Medicine, and associate director of the T-Cell Engineering Laboratory that is part of Carl June’s group, both at the University of Pennsylvania. Dr. Shedlock received his Ph.D. in cell & molecular biology from the University of Pennsylvania, and a B.S. with Honors in biology from Ursinus College in Collegeville, Pennsylvania.